Innovating Works

TEXSA SYNTHETICS, S.A.

Inactiva
OPTORETINA: Optical imaging of retinal function for gene and cell therapies ASSOCIATION EUROPEENNE EURISY tramitó un H2020: ERC-2020-COG For patients suffering from inherited retinal diseases (IRDs), gene and cell therapies offer hope of preserving or restoring vision. Retinal...
2021-01-20 - 2026-03-31 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.